Publications:

Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML.

Biomarker Research

Wang, JingHan J; Ye, Xingnong X; Fan, Cuihua C; Zhou, Jie J; Luo, Shuna S; Jin, Jingxia J; Chen, Dan D; Zheng, Yan Y; Wu, Cai C; Zhu, Xiaoqiong X; Jin, Jie J; Huang, Jian J

Publication Date: 2020-11-25

Variant appearance in text: NRAS: 86T>C

PubMed Link: 33292606

Variant Present in the following documents:

• Main text

View BVdb publication page

Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One

Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS

Publication Date: 2018

Variant appearance in text: NRAS: V29A

PubMed Link: 29698444

Variant Present in the following documents:

• pone.0196434.s001.xlsx, sheet 1

View BVdb publication page